Oncology companies
18 companies
Myeloma Investment Fund
Accelerating life-extending therapies, treatments and cures for all myeloma patients.
Cancer Fund
We invest in cancer innovation, together.
EMCIFund
Igniting the path to sustainable and affordable innovation.
Debiopharm Innovation Fund
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases.
Omega Funds
Investing in the future of medicine.
Third Rock Ventures
At Third Rock, we push the boundaries of science and technology to make a difference in the lives of patients and their families.
Sofinnova Investments
Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.
Pappas Capital
Pappas Capital invests exclusively in the life science sector.
Droia Ventures
Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives.
Bioluminescence Ventures
We're biomedical researchers investing in a new generation of translational founders.
BrightEdge
Investing in innovation for impact. Reduce cancer mortality and advance health equity.
Takeda Ventures
Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.
Claris Ventures
Equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.
What If Ventures
We fund startups solving stigmatized healthcare problems.
Sanofi Ventures
Sanofi Ventures invests in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.
FemHealth Ventures
Investing in women’s health innovations.
Mass General Brigham Ventures
Mass General Brigham Ventures is an early-stage venture capital firm founded in 2008 to advance new life science technologies emerging from Mass General Brigham…
Boehringer Ingelheim Venture Fund
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.